August 7, 2019

What's New in Biologics
by Patricia Van Arnum, DCAT Editorial Director
With biologics assuming a greater
portion of the industry’s pipeline and commercialization strategies, what are key trends and company activity in this sector? To expanding roles of niche modalities in cell and gene therapies to advances in bioprocessing, DCAT Value Chain Insights takes an inside look.   Read More

The EU and Drug Shortages
by Patricia Van Arnum, DCAT Editorial Director

The European Medicines Agency has issued two guidance documents, respectively to pharmaceutical companies and EU national regulators, to develop
and coordinate actions to better prevent, identify, manage, and communicate information on drug shortages. Read More
DCAT Value Chain Insights is produced and distributed by the Drug, Chemical and Associated Technologies Association .
To learn more, please visit www.dcat.org .